The board (the "Board") of directors of Shenzhen Hepalink Pharmaceutical Group Co. Ltd. announces that Ms. Tan Xuan resigned as (i) a joint company secretary of the Company and (ii) an authorized representative with effect from October 27, 2021, in order to pursue other business and work commitments, which makes her no longer possible to spend sufficient time on the business of the Company. The Board further announces that Mr. Qian Fengqi ("Mr. Qian") has been appointed as a Joint Company Secretary and an Authorized Representative, with effect from October 27, 2021.